Epigenomics of hormone-driven cancers

In the Epigenomics of hormone-driven cancers group, current projects focus on 

• The role of 5-hydroxymethylation in human adipogenesis
• Profiling DNA hydroxy-/methylation and chromatin accessibility in human intervention studies
• Epigenetic mechanisms in cancer and metastasis development, with a focus on breast and prostate cancer
• Developing biomarkers for endogenous endocrine resistance in breast cancer
• Characterizing the enhancer methylome in prostate cancer
• The pan-prostate cancer methylome landscape